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Abstract  
Aims 
It is clear that aerobic training (AT) can delay pancreatic exhaustion and slow the 
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progression from prediabetes to T2DM, but there is little information about the effects 
of resistance training (RT) on people with prediabetes. To compare the effectiveness of 
RT and AT in improvement of metabolic control and beta cell function protection among 
people with prediabetes. 
Methods 
248 participants with prediabetes were randomized to three groups－AT (n=83), RT 
(n=82) and control (n=83). RT consisted of 13 different resistance exercises per session 
using elastic string. AT performed aerobic dance at 60~70% of maximum heart rate 
(HRmax). Both exercises were performed 6 months and 3 times/week. The 
improvement of metabolic control was the primary outcome and second outcomes were 
HOMA2-β and HOMA2-IR. Longitudinal changes between groups were tested with 
repeated-measures analysis. 
Results  
217 out of 248 participants finished the study, but all participants were included in the 
intention-to-treat analyses. There was no statistical difference in demographic 
characteristic (P > 0.05). The average HbA1c in three groups was 5.98, 5.92 and 5.95, 
respectively. Within-group analyses showed that fasting blood glucose (FBG), 
HOMA2-IR, HOMA2- decreased in RT group, whereas FBG and HbA1c decreased 
significantly in AT group. Change in HbA1c was not significantly greater in RT cohort 
than in AT cohort (P = 0.059), but the decrease in HbA1c in both exercise groups were 
higher than in control group (P<0.05).  
Conclusions 
Resistance training appears to improve metabolic control and preserve beta cell function 
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comparable to aerobic training in participants with prediabetes.   
Highlights: 1): Aerobic exercise and resistance exercise both improve glucose control. 
          2): Resistance training appears to preserve beta cell function to a degree 
comparable to that observed with aerobic exercise with prediabetes patients. 
Trial registration 
Clinicaltrials. gov Identifier: NCT 02561377. 
Key words  
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Introduction 
Impaired glucose regulation (IGR) is characteristic of prediabetes. The prevalence of 
IGR has dramatically increased in China, half of the entire adult (50.1%) have had 
prediabetes in 2010
1
. According to the 20-year China Da Qing Diabetes Prevention 
Study
2
,
 
92% of persons with impaired glucose tolerance (IGT) will progress to overt 
type 2 diabetes mellitus (T2DM) in 20 years, imposing a large health and economic 
burden on China. It has been showed that beta cell function decreased in patients with 
prediabetes
3-4
. Studies used hyperglycemic clamp in IGT patients found 35-62% 
reduction in first-phase and 30-51% reduction in second-phase of insulin secretion 
compared with normal glucose tolerance (NGT)
5-6
. Autopsy data indicated that the beta 
cell volume of impaired fasting glucose (IFG) patients was decreased by 40% compared 
with non-diabetic controls
7
. In addition, diabetes-associated complications may affect 
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patients with prediabetes as well as some individuals with insulin resistance and normal 
glucose tolerance
7-8
. To reverse the impending diabetes epidemic, it is clearly imperative 
to focus on prevention. Interventions for individuals with prediabetes should aim to 
improve insulin resistance, preserve islet beta cell mass, and prevent further loss of beta 
cell function. 
Exercise and diet are the cornerstones of diabetes management
9
. It is generally accepted 
that regular physical activity provides substantial health benefits to individuals with 
T2DM and prediabetes
10-11
. The Diabetes Prevention Program (DPP) showed that 
lifestyle intervention among people with prediabetes can reduce T2DM incidence by 
58%
11
. Aerobic training (AT) was used in DPP can improve insulin action, delay 
pancreatic exhaustion, and slow the progression from prediabetes to T2DM
11
. Another 
Resistance training (RT) improves insulin sensitivity
12
 in a rodent model and glycaemia 
control in patients with prediabetes
13-14
. An updated research result showed that 
supervised resistance training can prevent diabetes incidence in people with 
prediabetes
15
. A study which was combined with AT and RT, resulted in significantly 
improved glycemic control, central adiposity, musculoskeletal and aerobic fitness in a 
population of individuals with prediabetes
16
. Comparing to machine resistance training, 
elastic cord is a cheaper, safer, more convenient and effective sports equipment
17
. 
Therefore, in our study we used elastic cord. However, duration of these interventions 
was most relatively brief (10-12 weeks). Moreover, studies did not distinguish effects 
on beta cell function from effects on insulin sensitivity or allow for comparisons 
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between RT and AT. Both need to be understood if we are to implement optimal 
methods to delay or prevent the onset of T2DM. Accordingly, this study aimed to 
analyze improvement in metabolic control, beta cell function during a six-month 
intervention in prediabetes undergoing either resistance training or aerobic exercise. We 
hypothesized that six-month resistance exercise would have effects on decreasing 
HbA1c and improving HOMA2-, HOMA2-IR. 
METHODS 
Study Participants 
Participants were enrolled at Center 1 (The Affiliated Hospital of Integrated Traditional 
Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 
China) between January, 2014 and April, 2014. Participants were recruited at two other 
centers between May, 2014 and December, 2014 (Center 2, Danyang People’s Hospital 
of Jiangsu Province, Danyang, China; Center 3, The First Affiliated Hospital of Guangxi 
Medical University, Guangxi, China). Those who had a history of prediabetes (already 
diagnosed by OGTT) were administered a confirmatory OGTT. Those without a history 
of prediabetes were pre-screened to confirm eligibility. Inclusion criteria specified 
individuals of either sex <75 years old with prediabetes defined by any of the following 
three standards: 1) FBG between 100 mg/dL (5.6 mmol/L) and 125 mg/dL (6.9 mmol/L) 
(IFG) on two separate occasions. 2) Blood glucose concentration of 140 mg/dL 
(7.8mmol/L) to 199 mg/dL (11.0 mmol/L) two hours after ingestion of 75g oral glucose 
(IGT). 3) HbA1c between 5.7% and 6.4%
18
 on two occasions. Participants were 
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excluded if they had been diagnosed with diabetes, cardiovascular or cerebrovascular 
disease, were pregnant or breastfeeding, had severe physical disability, or lacked the 
intellectual or emotional capability to adhere to the study protocol.  
Trial Design and Randomization 
A total of 248 participants met inclusion criteria and were invited to participate in the 
study. The flow diagram of this study was shown in Fig. 1. Participants were assigned to 
one of three groups using numbers generated randomly by computer: (1) a control group 
(C group, n=83); (2) an aerobic training group (AT group, n=83); (3) a resistance 
training group (RT group, n=82). The study was approved by the ethics committee of 
the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine. 
Participants provided written informed consent prior to enrollment. 
Screening maximal oxygen consumption (VO2max) 
For safety purposes, a modified Bruce protocol treadmill test (ERS.2, Ergoline, German) 
was used to determine maximum heart rate (HRmax) and VO2max before starting the 
exercise program. Throughout the treadmill test we monitored participant blood 
pressure and heart rate according to standard procedures and terminated the test when 
the participant reached volitional fatigue. During the test, the heart rate of patients was 
monitored by a heart rate watch (Polar® A370, Polar, Finland), and each individual’s 
HRmax was defined when they rate their dyspnea and fatigue. All participants were 
performed continuous monitoring of electrocardiogram during these maximal exercise 
tests. Those found to have typical angina pectoris, syncope, systolic blood pressure drop 
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≥10mmHg, sustained ventricular tachycardia and ST elevation of ≥1.0 mm were 
excluded from the this study.  
Exercise Programs 
Aerobic training program 
Participants participated in the AT sessions 3 times/week for 60 minutes/session under 
the supervision of a qualified research nurse (including 5 minutes of warm-up, aerobic 
dancing for 50 minutes and 5 minutes of stretching exercises). Participants performed 
aerobic dancing at 60~70% of their HRmax as determined by their treadmill test result. 
Heart rate was monitored by Polar during training, which was connected to the 
computer. When the heart rate exceeded 60~70% of their HRmax, we would adjust the 
scheme. The target heart rate range was progressively increased as described. The 
exercise component was aerobic dancing derived from a previously published diabetes 
quantitative exercise research project in one of our study centers, the First Affiliated 
Hospital of Guangxi Medical University, Guangxi, China. 
Resistance training program 
Participants were involved in RT sessions 3 times/week supervised by our research 
assistants in the gardens of 2 hospitals (Nanjing and Danyang), and the community 
squares (Guangxi Guilin). There were 13 exercise pieces in the protocol: leg presses, leg 
extensions, chest presses, pull downs, rowing motions, calf raise, seated leg curl, 
shoulder presses, straight-arm forwards, straight-arm backwards, leg rotation left, leg 
rotation right and abdominal crunch movements. The protocol took approximately 50 
minutes to complete.  
Strength was assessed at baseline by performing a one repetition maximum (1RM) test 
(NitroPlus, Nautilus, Inc., Vancouver, WA, USA) on the press and extension of arms 
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and legs, and we accurately corrected the resistance by measuring 1RM throughout the 
RT intervention. The resistance for each bungee cord during the first 1-2 weeks was set 
by the trainers at 50% of 1RM, with frequency of 1-2/week, and 6-8 repetitions of 13 
different activities. And then gradually increased to 3/week, 10-15 repetitions at 60% of 
1RM until completing the intervention
15
.  
Oral glucose tolerance test (OGTT) 
Before and after the experimental period, blood was drawn after an overnight fasting 
and 2-hour after 75g glucose intake. Post-tests were conducted within 7 days after the 
end of the intervention period. For personal issues, 6 subjects had their blood drawn 14 
days after the end of the intervention period.  
OGTT was performed by administering a 75 g glucose solution after a 10-h fast with 
plasma glucose sampling before and 120 min after glucose administration. The OGTT 
was performed both before and after the completion of the six-month exercise program. 
Plasma glucose was analyzed by a YSI 2700 Select Biochemistry Analyzer (YSI, Inc, 
Yellow Springs, OH). Serum insulin was measured by solid-phase, enzyme-labelled 
chemiluminescent immunometric assay (Immulite 2000; Diagnostic Products, Los 
Angeles, CA). HbA1c was determined by high performance liquid chromatography 
(Bio-Rad Diamat, Munich, Germany). 
Blood lipid assays 
 The fasting serum concentrations of total cholesterol, high-density lipoprotein (HDL) 
cholesterol, low-density lipoprotein (LDL) cholesterol and plasma triacylglycerol were 
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determined by colorimetric methods using commercial kits (Abbott, Abbott Park, IL) 
with an Architect c8000 analyzer (Abbott) according to the instructions of the 
manufacturer. 
Anthropometric measures  
Body weight and height were measured in all participants wearing light clothing and 
standing barefoot. Body mass index (BMI) was calculated from weight and height 
(kg/m
2
). Waist circumference was measured at the midpoint between the lower ribs and 
the iliac crest at the end of normal expiration. The method of measuring abdominal 
adipose tissue was reported elsewhere
19
. 
 Diet and physical activity 
 All participants were asked to follow a healthy diet (55-60% carbohydrate, 15-20% 
protein, and 25-30% fat) throughout the study. Individualized meal plans were made by 
the dietitian and they were asked to record their 24-hour food intake during the 
enrollment period and throughout the six-month study.  
 Participants completed a questionnaire to quantify their routine physical activity before 
entry into the study. Participants were asked to record the frequency (days/week) and 
duration (h and min/day) of daily physical activity. All participants were requested to 
maintain habitual physical activity throughout the intervention. 
Statistical analyses  
Power and sample size calculations were based on a predicted HbA1c difference of 0.66 
HbA1c units with an SD of effect of 1.2 HbA1c units
20
. The required sample size for 
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80% power using a 2-tailed test at alpha=0.05 is 70 each group and an expected dropout 
rate of 15%. Thus, we aimed to recruit 242 subjects in total. Finally, 248 subjects were 
enrolled in this study. Analysis used the intention-to-treat principle and included all 
randomly allocated participants. The normality of distribution was assessed by 
skewness and kurtosis analysis. Baseline data were compared with the use of one-way 
analysis of variance (ANOVA) or Kruskal-Wallis analysis. A Chi quadrate test for 
categorical variables. Within-group comparisons (baseline and six months) used paired 
t-tests. Longitudinal changes between groups were tested with the use of 
repeated-measures analysis of variance. Statistical significance was defined as P < 0.05. 
Statistical analyses were performed using SPSS 24.0 (SPSS Inc, Chicago, IL, USA).  
 
RESULTS 
248 patients were included, and 217 patients completed the 6-month study, so the 
adhesion rate is 87.5%. Throughout the study period, no exercise-related adverse events 
were found. The dropouts in AT, RT and control group were 10, 11, and 10, respectively. 
As shown in Table 1, there were no differences in baseline variables across groups. The 
mean age in AT group was 60.93, RT group was 59.91 and control group was 60.73. The 
average HbA1c in three group was 5.98, 5.92 and 5.95, respectively.  
As shown in Table 2, there were several statistically significant differences in metabolic 
outcomes among three groups and between the aerobic and resistance exercise groups. 
After training, no significant difference was found in the change of HbA1c between AT 
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and RT (P=0.059). But both were significantly better than the control group 
(Group-by-time interaction P <0.001). With respect to FBG, the change of FBG was 
(-0.04 ([-0.07, -0.01]) in the AT group, (-0.07 ([-0.10, -0.04]) in the RT group and (0.06 
([0.03, 0.09], [square root mean, 95% CI]) in the control group (Group-by-time P＜
0.001). However, there was no significant difference between the AT and RT groups. At 
six months, both the AT and RT groups experienced significant improvement in 
HOMA2-β vs. the control group (Group-by-time interaction P<0.001). The 
improvement in HOMA2-β was no significantly greater in the resistance exercise group 
(0.36 [0.04, 0.69]) than in the aerobic exercise group (0.15 [-0.19, 0.49] [square root 
mean, 95% CI], P = 0.7). Body weight, BMI, 2hPG and SBP improved in both exercise 
groups compared to controls (P <0.05); although body weight, BMI, 2hPG and SBP 
decreased more in the AT group than among those in the RT group, the differences were 
not statistically significant. 
Figures 2, 3 and 4 depicts the range of individual subjects’ responses among three 
groups. After aerobic exercise, 45.8% of the participants showed reduction in HbA1c, 
54.2%, 57.8%, and 51.8% of participants showed a decrease in 2hPG, FBG, HOMA2-IR, 
and HOMA2- was improved in 53% of participants, respectively (Fig. 2). Resistance 
exercise decreased HbA1c in 37.8% of participants, 40.2%, 58.5%, and 57.3% of the 
participants had reductions in 2hPG, FBG and HOMA2-IR, and HOMA2- was 
improved in 50.0% of participants, respectively (Fig. 3). In the controls, 22.9% of the 
participants had a decrease in HbA1c, and the percent decreases in 2hPG, FBG and 
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HOMA2-IR were 28.9%, 16.9%, 38.6%, 28.9% of participants had an increase in 
HOMA2-, respectively (Fig. 4). 
Fig. 5 depicts results for HbA1c, 2hPG, FBG, HOMA2-IR, HOMR2-β and insulin 
before and after six-month intervention. AT but not RT caused a reduction in HbA1c 
(P=0.041, P=0.361). Participants in the RT and AT group showed no significant 
decrease in 2hPG (P =0.079, P =0.691). FBG decreased significantly in both exercise 
groups (P＜0.01). Both HOMA2-IR and HOMA2- were improved significantly in RT 
group (P=0.005, P=0.049). But in the control group, HOMA2-β was significantly 
decreased compared with baseline (P＜0.001). Among control participants, HbA1c, 
2hPG and FBG significantly increased after six months (P＜0.01).  
We also tried some correlations between variables. The Spearman results showed that 
there was no correlation between Statins use and A1c (P=0.313), or hypotensive drugs 
and A1c (P=0.292). 
Discussion 
In this study of the effects of exercise in participants with prediabetes, we have both 
confirmed the well-recognized efficacy of aerobic training in preventing T2DM and in 
addition, demonstrated for the first time a set of comparable benefits of resistance 
training. These include the demonstration that RT improves metabolic control and beta 
cell function to a degree comparable to that observed with AT. 
A novel finding of this study was that, compared to controls, both AT and RT showed 
significant improvement in HbA1c, but no significant improvement in RT was observed 
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in HbA1c relative to baseline. Previous studies did not measure or failed to prove that 
the improvement in A1c with RT
21-25
. Most of them did not measure A1c
21-22,24-25
, and 
one study that did check A1c was only 12-week in duration
23
, with 36 prediabetes  
patients in RT group, 39 in Nordic Walking group, and 40 in control group, and they did 
not reach statistical significance, because A1c requires a relatively long trial to observe 
its improvement, especially for patients with predaibetes, whose A1c was 5.4%-5.5%. 
On the other hand, even though the participants were randomized into 3 groups in 
previous study, the UKK fitness index in the RT group were much lower than those in 
the control and Nordic Walking group, which could partially cause insignificant 
difference in A1c between RT and control group. A larger sample size in our study may 
have given us the statistical power to detect improvement in A1c. A meta-analysis 
showed that RT had a clinically and statistically significant effect on A1c for patients 
with “abnormal glucose metabolism”, but inspection of the 13 studies included in that 
analysis revealed that in 11 studies A1c was measured in patients with T2DM, and only 
two studies targeted prediabetes. The latter two studies did not report A1c
14
. The Health 
Professionals Follow-up Study observed men engaged in RT over a period of 18 years 
and showed a 34% reduction in risk of T2DM
26
, but unfortunately, A1c was not reported 
either. Our data suggest that six-month of moderate RT with 150min /week can improve 
A1c in patients with prediabetes. 
It has been well established that aerobic exercise can increase insulin sensitivity and 
protect beta cell function in patients with prediabetes
27-28
. Our study reveals that 
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six-month of moderate resistance training was as effective as aerobic training in 
decreasing HOMA2-IR and increasing HOMA2-β in patients with prediabetes. It has 
also been reported that moderate short-term resistance training (≤12-week) can improve 
blood glucose control
13-14
 and that intense RT can enhance insulin sensitivity during RT 
in patients with prediabetes
29
 and in obese adolescents
30
. Our results demonstrate that 
six-month of RT not only improved insulin resistance, but also importantly protected 
beta cell function in patients with prediabetes, a finding previously absent in the 
literature
21-26
. 
Several possible mechanisms could explain the efficacy of RT in preserving beta cell 
function. Firstly RT may up-regulate HK2 and GLUT4, two key regulators of insulin 
mediated glucose transport in contracting skeletal muscle. This could in turn enable 
greater glucose flux across the plasma membrane
31
. Secondly, RT increases energy 
expenditure, decreasing blood glucose concentration, thereby reducing insulin 
requirements. Thirdly, RT may increase lean body mass for patients with type 2 
diabetes
32
,
 
decrease fat mass
33
,
 
decrease visceral fat and its associated inflammatory 
markers
34
, decrease oxidative stress, and increase mitochondrial oxidative capacity
35
. In 
aggregate, these effects could contribute to the preservation of beta cell function.  
Beta cell function is a stronger predictor of change in glycaemia control after an 
exercise intervention than is change in insulin sensitivity
36
.
 
Decrease in beta cell 
function is a key to developing diabetes
37
. In addition, as with AT, RT can improve beta 
cell function. For all of these reasons, RT appears to have the potential to be an effective 
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way to prevent T2DM in at-risk in patients. 
Insulin resistance is commonly associated with prediabetes. After six months of exercise, 
we found that HOMA2-IR decreased in both RT and AT groups compared with the 
control group, but there were no significant differences between the two intervention 
groups. Previous studies have failed to measure or document an improvement in 
HOMA-IR
21-25
. Many studies did not measure changes of HOMA-IR with resistance 
exercise in persons with prediabetes
21-22,25
. Two other studies examining insulin 
resistance did not find a statistical significant improvement in insulin resistance
23-24
. 
Laurie et. al observed an acute enhancement to insulin sensitivity during brief but 
intensive RT in patients with impaired fasting glucose
29
, but this acute increase of 
insulin sensitivity was diminished after stopping RT. Our study showed that longer (six 
months) regular (3 times 150 min total/week) moderate RT can significantly maintain 
the improvement in insulin sensitivity. 
We recognize that failure to observe changes in HOMA2-IR with resistance exercise in 
persons with prediabetes has been reported
21,23
. We would argue that the discrepancy 
can be explained by differences in duration (six months vs.12 weeks), statistical power 
(sample sizes of 248 vs. 144 and 159), the frequency of exercise (3 times/week vs. 2 
times/week
21
 vs. not specified
23
), and the different measures of HOMA-IR (HOMA2-IR 
vs HOMA-IR). 
Limitations: We didn’t have any follow-up measures of VO2max, strength mainly due 
to a safety reason, for the subjects were old people with an average age of 60 years old 
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and they were exhausted during the first time measuring VO2max. In addition, for male 
patients with prediabetes were reluctant to participate the program, we recruited more 
female participants in this study, this may cause bias to the results. In conclusion, our 
study indicates that six-month of RT can achieve comparable improvements in beta cell 
function to that achieved by aerobic exercise to prevent the development of type 2 
diabetes. 
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Figure legends 
Fig. 1. Study flow diagram. 
Fig. 2. Subjects with pre-diabetes underwent six months of aerobic exercise. HbA1c, 
2hPG, FBG, HOMA2-IR, HOMA2-β and insulin in response to exercise were measured 
as the post-exercise minus pre-exercise (Δ) values. The X-axis represents each 
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individual subject’s data point. Y-axis data above and below the origin indicate increases 
and decreases, respectively in each variable in response to aerobic exercise. 
Fig. 3. Subjects with pre-diabetes underwent six months of resistance exercise. HbA1c, 
2hPG, FBG, HOMA2-IR, HOMA2-β and insulin in response to exercise were measured 
as the post-exercise minus pre-exercise (Δ) values. The X-axis represents each 
individual subject’s data point. Y-axis data above and below the origin indicate increases 
and decreases, respectively in each variable in response to resistance exercise. 
Fig. 4. Subjects with pre-diabetes underwent six months of non-exercise. The 
responsiveness of HbA1c, 2hPG, FBG, HOMA2-IR, HOMA2-β and insulin were 
measured as the post-values minus (Δ) pre-values. The X-axis is the individual subject 
data points. The X-axis represents each individual subject’s data point. Y-axis data 
above and below the origin indicate increases and decreases, respectively in each 
variable in controls who did not exercise. 
Fig. 5. HbA1c, 2hPG, FBG, HOMA2-IR, HOMA2-β and insulin in the three group 
before and after exercise. *P<0.05, **P<0.01 between baseline and after six months of 
intensive physical training. 
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Table 1. Baseline characteristics 
Variables Aerobic group  (n=83) Resistance group  (n=82) Control group  (n=83) P 
Sex(female/male) 59/24 52/30 50/33 0.322 
Age(yr) 60.93±5.71 59.91±5.92 60.73±5.83 0.496 
Body weight(kg) ( median25%,75%) 61.24 (54.00, 68.00) 62.95 (53.90, 71.60) 63.73 (56.00, 70.60) 0.166  
BMI (kg/m2) 24.69±2.78 24.81±3.19 25.04±2.86 0.743  
WC(cm) ( median25%,75%) 85.69 (79.00, 93.00) 85.59 (78.75, 93.00) 86.02 (81.00, 92.00) 0.597 
HC(cm) ( median25%,75%) 95.56 (92.00, 100.00) 96.86 (91.00, 102.00)  96.30 (92.50, 100.00) 0.994  
VAT(cm2) 148.02 ± 52.93 135.22 ± 59.51 155.80 ± 66.24 0.380 
SAT(cm2) 205.38 ± 70.60 202.02 ± 83.49 209.69 ± 89.90 0.910 
SBP(mmHg) ( median25%,75%) 135.51 (123.00, 148.00) 131.65 (122.00, 138.25) 136.75 (123.00, 150.00) 0.059 
DBP(mmHg) ( median25%,75%)  80.57 (73.00, 89.00) 77.99 (70.00, 88.00) 81.47 (76.00, 88.00) 0.129 
VO2Max 21.56 ± 4.32 22.34 ± 2.78 21.79 ± 4.10 0.450 
FBG(mmol/l) ( median25%,75%) 5.87 (5.60, 6.30) 5.97 (5.60, 6.30) 5.83 (5.29, 6.20) 0.370  
2hPG(mmol/l) ( median25%,75%) 7.61 (6.80, 8.70) 7.72 (6.50, 8.65) 8.06 (7.00, 8.87) 0.165 
HbA1C(%) ( median25%,75%) 5.98 (5.70, 6.30) 5.92 ( 5.70, 6.20) 5.95 (5.70, 6.30) 0.525 
HbA1C(mmol/L) ( median25%,75%) 42.08 (38.80, 45.90) 42.08 (38.80, 45.35) 40.98 (38.80, 45.35) 0.420 
Insulin(µU/ml) 10.96±4.16 11.14 ± 4.26 11.10 ± 3.77 0.958 
HOMA2-IR 1.47±0.54 1.50±0.56 1.48±0.48 0.954 
HOMA2-β ( median25%,75%) 86.90 (66.80, 109.80) 87.01 (70.08, 99.85) 93.62 (66.70, 105.70) 0.714 
TC(mmol/l) 5.30±0.99 5.20 ± 0.92 5.17 ± 0.97 0.656 
TG(mmol/l) ( median25%,75%) 1.86 (1.16, 2.43) 1.88 (1.08, 2.55) 1.89 (1.02, 2.44) 0.822 
HDL(mmol/l) ( median25%,75%) 1.54 (1.25, 1.72) 1.47 (1.27, 1.68) 1.44 (1.17, 1.60) 0.081 
LDL(mmol/l) ( median25%,75%) 3.21 (2.73, 3.75) 3.07 (2.62, 3.47) 2.95 (2.43, 3.36) 0.073 
Menopause 59 52 50 0.322 
Statins use 10 11 5 0.256 
Hypoglycemic drugs  0 0 0 _ 
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Data are shown as means ± SD or median. BMI: Body mass index; WC: Waist circumference; HC: Hip circumference; VAT: Visceral adipose tissue; SAT: subcutaneous adipose tissue; 
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FBG: Fasting blood glucose; 2hPG: Venous plasma glucose concentration 2h after intake of 75g oral glucose; 
HOMA2-IR and HOMA2- were calculated by a software of the HOMA2 model to assess insulin resistance and beta function; TC: Total cholesterol; TG: Triacyl glycerol; 
HDL: High density lipoprotein cholesterol; LDL: Low density lipoprotein cholesterol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypotensive drugs  21 18 29 0.151 
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Table 2. Changes of glycaemia control and lipid profile in aerobic group and resistance group 
 
Outcome 
 
Aerobic group 
 
Resistance group 
 
Control group 
P value 
Group-time Main effects 
of group 
Interaction       
 Aerobic 
 vs. 
   Resistance  
    Aerobic 
    vs. 
    Control 
  Resistance 
 vs. 
 Control 
Body weight (kg)
b
                                          
 
            
 
 
       
  
       
    Pre-exercise  7.81 (7.68, 7.94) 7.91 (7.76, 8.05) 7.96 (7.84, 8.09)
**
 
post-exercise  7.77 (7.64, 7.90) 7.88 (7.74, 8.02) 8.02 (7.89, 8.14)      
Change -0.04 (-0.08, -0.003) -0.03 (-0.09, -0.04) 0.05 (0.03, 0.08) 0.006           0.814 0.001 <0.001 
BMI (kg/m
2
)             
  Pre-exercise   24.70 (24.09, 25.32) 24.81 (24.11, 25.51) 25.04 (24.42, 25.66)
**
  
            
   
  post-exercise 24.45(23.81, 25.08) 24.68 (23.96, 25.40) 25.38 (24.74, 26.01)     
  Change -0.25 (-0.49, -0.01) -0.13 (-0.50, 0.24) 0.33 (0.17, 0.50) 0.006           0.828 0.001 <0.001 
FBG (mmol/l)
b
        
   Pre-exercise 2.42 (2.39, 2.44)
**
 2.44 (2.42, 2.47)
**
 2.41 (2.38, 2.44)
**
  
            
   
   post-exercise 2.38 (2.35, 2.41) 2.37 (2.34, 2.40) 2.47 (2.44, 2.50)     
   Change -0.04 (-0.07, -0.01) -0.07 (-0.10, -0.04) 0.06 (0.03, 0.09) <0.001          0.284 <0.001 <0.001 
2hPG (mmol/l)
b
        
  Pre-exercise  2.74 (2.67, 2.80) 2.76 (2.70, 2.83) 2.82 (2.76, 2.89)
**
  
            
   
  post-exercise 2.67 (2.61, 2.74) 2.77 (2.70, 2.84) 2.96 (2.89, 3.03)      
  Change -0.07 (-0.14, 0.01) -0.01 (-0.08, 0.09) 0.13 (0.05, 0.22)         0.002           0.249 <0.001 0.01 
HbA1c (%)
b
        
   Pre-exercise  2.44 (2.43, 2.46)
*
 2.43 (2.42, 2.45) 2.44 (2.42, 2.45)
**
  
            
   
   post-exercise 2.43 (2.41, 2.45) 2.44 (2.42, 2.45) 2.48 (2.46, 2.50)      
   Change -0.01 (-0.02, 0.0001) 0.01 (-0.01, 0.02) 0.05 (0.03, 0.06) <0.001          0.059 <0.001 0.02 
Insulin (μU/ml)        
  Pre-exercise  10.91 (10.00, 11.82) 11.14 (10.20, 12.08)
*
 11.10 (10.28, 11.92)     
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  post-exercise 10.34 (9.52, 11.14) 10.34 (9.42, 11.26) 10.62 (9.90, 11.35)                   
  Change 
HOMA2-IR 
-0.57 (-1.42, 0.28) -0.80 (-1.47, -0.13) -0.48 (-1.05, 0.09) 0.802        0.912          0.594 0.773 0.376 
  Pre-exercise 1.46 (1.35, 1.58) 1.50 (1.37, 1.62)
**
 1.48 (1.37, 1.58)  
            
    
  post-exercise 1.37 (1.27, 1.48) 1.37 (1.25, 1.49) 1.44 (1.34, 1.53)      
  Change -0.09 (-0.20, 0.02) -0.13 (-0.21, -0.04) -0.04 (-0.12, 0.03) 0.409        0.865 0.497 0.450 0.068 
HOMA2-βb        
   Pre-exercise  9.32 (9.00, 9.64) 9.21 (8.89, 9.54)* 9.51 (9.11, 9.90)
**
  
            
   
   post-exercise
 
 9.47 (9.10, 9.84) 9.58 (9.17, 9.98) 8.89 (8.59, 9.19)    
   Change 0.15 (-0.19, 0.49) 0.36 (0.04, 0.69) -0.62 (-0.91, -0.32) <0.001          0.700 0.001 0.001 
SBP (mmHg)
b
        
   Pre-exercise   11.62 (11.46, 11.77)
**
 11.46 (11.32, 11.59)
**
 11.67 (11.53, 11.82)  
            
   
   post-exercise 11.29 (11.14, 11.44) 11.24 (11.10, 11.37) 11.71 (11.54, 11.87)      
   Change -0.33 (-0.47, -0.18) -0.22 (-0.36, -0.08) 0.03 (-0.05, 0.11) <0.001          0.391 <0.001 0.005 
DBP (mmHg)
b
        
  Pre-exercise 8.96 (8.81, 9.10)
*
 8.81 (8.66, 8.95) 9.01 (8.89, 9.13)  
            
   
  post-exercise 8.80 (8.66, 8.93) 8.71 (8.57, 8.85) 8.95 (8.83, 9.08)      
  Change -0.16 (-0.30, -.0.02) -0.09 (-0.23, 0.04) -0.06 (-0.20, 0.08) 0.574        0.030 0.476 0.137 0.482 
TC (mmol/l)        
  Pre-exercise 5.30 (5.08, 5.52) 5.20 (4.99, 5.40) 5.17 (4.96, 5.38)  
            
   
  post-exercise 5.20 (4.96, 5.44) 5.25 (5.02, 5.48) 5.41 (5.19, 5.62)    
  Change -0.09 (-0.26, 0.07) 0.05 (-0.13, 0.23) 0.24 (0.18, 0.29) 0.078        0.898   0.652   0.113  0.252 
TG (mmol/l)
a
        
  Pre-exercise
 
 0.23 (0.18, 0.27) 0.21 (0.16, 0.26) 0.21 (0.15, 0.26)  
            
   
  post-exercise  0.23 (0.19, 0.28) 0.21 (0.16, 0.25) 0.24 (0.18, 0.29)    
  Change 0.01 (-0.03, 0.04) -0.01 (-0.05, 0.03) 0.03 (-0.02, 0.08) 0.400        0.839   0.666   0.538   0.141  
HDL (mmol/l)
b
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For all variables, the results are means (95% CI). FBG: Fasting blood glucose; 2hPG: Venous plasma glucose concentration 2h after intake of 75g oral glucose; 
HOMA2-IR and HOMA2- were calculated by a software of the HOMA2 model to assess insulin resistance and beta function; SBP: Systolic blood pressure; DBP: 
Diastolic blood pressure; TC: Total cholesterol; TG: Triacylglycerol ; HDL: High density lipoprotein; LDL: Low density lipoprotein. P represents the comparison of 
changes between the groups.* Statistically significant for the comparison of the value at the follow-up time with the baseline value within the group, *p<0.05, 
**p<0.01. 
a
 Logarithmic transformation (log10) performed 
b
 Square root transformation performed 
 
 
  Pre-exercise  1.23 (1.20, 1.26) 1.20 (1.17, 1.23) 1.19 (1.16, 1.23)  
            
   
  post-exercise 1.24 (1.20, 1.29) 1.26 (1.21, 1.30) 1.20 (1.17, 1.24)    
  Change 0.01 (-0.02, 0.04) 0.05 (0.02, 0.09) 0.01 (-0.03, 0.05) 0.193         0.145   0.535    0.601   0.834  
LDL (mmol/l)
b
        
  Pre-exercise 1.78 (1.73, 1.82) 1.74 (1.70, 1.78) 1.70 (1.65, 1.75)
**
  
 
   
  post-exercise
 
  1.81 (1.76, 1.87) 1.74 (1.69, 1.79) 1.82 (1.77, 1.86)    
  Change 0.04 (-0.01, 0.09) -0.002 (-0.05, 0.05) 0.11 (0.07, 0.16) 0.004              0.268    0.046    <0.001  
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